Clinical Study
Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
Table 1
The characteristic of 107 participants (54 in metformin group and 53 in repaglinide group) with type 2 diabetes, diagnosed according to World Health Organization criteria.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are shown by means and standard errors. It was only different in TC between men and women of repaglinide group (). |